An Update on Newer Topical Therapies for Actinic Keratoses; Advances and Applications

February 2003 | Volume 2 | Issue 1 | Original Article | 35 | Copyright © 2003

James Q. del Rosso, Do, FAOCD

Abstract

The use of topical agents for treatment of most dermatologic disorders is integral to the practice of dermatology. The innate properties and therapeutic mechanisms of the active component(s) of a topical preparation and the ability of the vehicle formulation to deliver adequate concentrations of drug to the site of disease directly affect clinical efficacy. Other factors influencing efficacy in clinical practice correlate closely with the extent of patient compliance, including the degree of local tolerability and patient acceptability of the product, frequency of application and duration of therapy. The following provides a discussion of newer medical therapies for the treatment of actinic keratosis based on current literature and clinical experience.

Purchase Original Article

Purchase a single fully formatted PDF of the original manuscript as it was published in the JDD.

Download the original manuscript as it was published in the JDD.

Contact a member of the JDD Sales Team to request a quote or purchase bulk reprints, e-prints or international translation requests.

To get access to JDD's full-text articles and archives, upgrade here.

Save an unformatted copy of this article for on-screen viewing.

Print the full-text of article as it appears on the JDD site.

→ proceed | ↑ close

Related Articles